ID

29144

Description

Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00753181

Lien

https://clinicaltrials.gov/show/NCT00753181

Mots-clés

  1. 01/03/2018 01/03/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

1 mars 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes Mellitus, Type 2 NCT00753181

Eligibility Diabetes Mellitus, Type 2 NCT00753181

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. type 2 diabetes
Description

Diabetes Mellitus, Non-Insulin-Dependent

Type de données

boolean

Alias
UMLS CUI [1]
C0011860
2. hba1c >6.5% and <11.0%
Description

Glucohemoglobin measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0202054
3. male/non-pregnant, non-lactating female, at least 6 months postpartum
Description

Gender | Pregnancy Absent | Breast Feeding Absent | Postpartum

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0032961
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0006147
UMLS CUI [3,2]
C0332197
UMLS CUI [4]
C0086839
4. if female of childbearing potential, practicing method of birth control
Description

Childbearing Potential Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
5. body mass index > 18.5 kg/m2 and < 43.0 kg/m2.
Description

Body mass index

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
6. weight stable for past two months
Description

Stable body weight Duration

Type de données

boolean

Alias
UMLS CUI [1,1]
C0517386
UMLS CUI [1,2]
C0449238
7. if on anti-hypertensive, lipid-lowering, thyroid medication or hormone therapy, dosage constant for at least two months
Description

Antihypertensive Agents Dosage Stable | Hypoglycemic Agents Dosage Stable | Antithyroid Agents Dosage Stable | Hormone Therapy Dosage Stable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0003364
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2,1]
C0020616
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
UMLS CUI [3,1]
C0040125
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0205360
UMLS CUI [4,1]
C0279025
UMLS CUI [4,2]
C0178602
UMLS CUI [4,3]
C0205360
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. uses injected medications (e.g., insulin, exenatide) for glucose control.
Description

Pharmaceutical Preparations Injection Blood Glucose Control | Insulin | exenatide

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1828121
UMLS CUI [1,3]
C0005802
UMLS CUI [1,4]
C0243148
UMLS CUI [2]
C0021641
UMLS CUI [3]
C0167117
2. history of diabetic ketoacidosis
Description

Diabetic Ketoacidosis

Type de données

boolean

Alias
UMLS CUI [1]
C0011880
3. current infection ; inpatient surgery, or corticosteroid treatment in the last 3 months or antibiotics in the last 3 weeks
Description

Communicable Disease | Inpatient Operative Surgical Procedures | Adrenal Cortex Hormones | Antibiotics

Type de données

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2,1]
C0021562
UMLS CUI [2,2]
C0543467
UMLS CUI [3]
C0001617
UMLS CUI [4]
C0003232
4. active malignancy
Description

Malignant Neoplasms

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
5. states he/she has had a significant cardiovascular event < 12 weeks prior to study entry or history of congestive heart failure in the last 12 months.
Description

Cardiovascular event | Congestive heart failure

Type de données

boolean

Alias
UMLS CUI [1]
C1320716
UMLS CUI [2]
C0018802
6. end stage organ failure
Description

Organ failure End-stage

Type de données

boolean

Alias
UMLS CUI [1,1]
C0349410
UMLS CUI [1,2]
C0205088
7. active metabolic, hepatic, or gastrointestinal disease that may interfere with nutrient absorption, distribution, metabolism, or excretion (such as gastroparesis), excluding diabetes.
Description

Metabolic Disease Interferes with Nutrient absorption | Liver disease Interferes with Nutrient absorption | Gastrointestinal Disease Interferes with Nutrient absorption | Metabolic Disease Interferes with Nutrients Distribution | Liver disease Interferes with Nutrients Distribution | Gastrointestinal Disease Interferes with Nutrients Distribution | Metabolic Disease Interferes with Nutrients Metabolism | Liver disease Interferes with Nutrients Metabolism | Gastrointestinal Disease Interferes with Nutrients Metabolism | Metabolic Disease Interferes with Nutrients Excretion | Liver disease Interferes with Nutrients Excretion | Gastrointestinal Disease Interferes with Nutrients Excretion | Gastroparesis | Exception Diabetes

Type de données

boolean

Alias
UMLS CUI [1,1]
C0025517
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C1961155
UMLS CUI [2,1]
C0023895
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C1961155
UMLS CUI [3,1]
C0017178
UMLS CUI [3,2]
C0521102
UMLS CUI [3,3]
C1961155
UMLS CUI [4,1]
C0025517
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C0678695
UMLS CUI [4,4]
C1378698
UMLS CUI [5,1]
C0023895
UMLS CUI [5,2]
C0521102
UMLS CUI [5,3]
C0678695
UMLS CUI [5,4]
C1378698
UMLS CUI [6,1]
C0017178
UMLS CUI [6,2]
C0521102
UMLS CUI [6,3]
C0678695
UMLS CUI [6,4]
C1378698
UMLS CUI [7,1]
C0025517
UMLS CUI [7,2]
C0521102
UMLS CUI [7,3]
C0678695
UMLS CUI [7,4]
C0025519
UMLS CUI [8,1]
C0023895
UMLS CUI [8,2]
C0521102
UMLS CUI [8,3]
C0678695
UMLS CUI [8,4]
C0025519
UMLS CUI [9,1]
C0017178
UMLS CUI [9,2]
C0521102
UMLS CUI [9,3]
C0678695
UMLS CUI [9,4]
C0025519
UMLS CUI [10,1]
C0025517
UMLS CUI [10,2]
C0521102
UMLS CUI [10,3]
C0678695
UMLS CUI [10,4]
C0221102
UMLS CUI [11,1]
C0023895
UMLS CUI [11,2]
C0521102
UMLS CUI [11,3]
C0678695
UMLS CUI [11,4]
C0221102
UMLS CUI [12,1]
C0017178
UMLS CUI [12,2]
C0521102
UMLS CUI [12,3]
C0678695
UMLS CUI [12,4]
C0221102
UMLS CUI [13]
C0152020
UMLS CUI [14,1]
C1705847
UMLS CUI [14,2]
C0011847
8. chronic, contagious, infectious disease, such as active tuberculosis, hepatitis b or c, or hiv.
Description

Chronic disease | Communicable Disease | Tuberculosis | Hepatitis B | Hepatitis C | HIV Infection

Type de données

boolean

Alias
UMLS CUI [1]
C0008679
UMLS CUI [2]
C0009450
UMLS CUI [3]
C0041296
UMLS CUI [4]
C0019163
UMLS CUI [5]
C0019196
UMLS CUI [6]
C0019693
9. use of herbals, dietary supplements, or medications, other than allowed medications, during past four weeks that could profoundly affect blood glucose.
Description

Plant Preparations Affecting Blood Glucose | Dietary Supplements Affecting Blood Glucose | Pharmaceutical Preparations Illicit Affecting Blood Glucose

Type de données

boolean

Alias
UMLS CUI [1,1]
C0949854
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0005802
UMLS CUI [2,1]
C0242295
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0005802
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C0332266
UMLS CUI [3,3]
C0392760
UMLS CUI [3,4]
C0005802
10. symptomatic in response to blood collection prior to enrollment into this study.
Description

Response Symptomatic Collection of blood specimen

Type de données

boolean

Alias
UMLS CUI [1,1]
C0871261
UMLS CUI [1,2]
C0231220
UMLS CUI [1,3]
C0005834
11. clotting or bleeding disorders.
Description

Blood Coagulation Disorders

Type de données

boolean

Alias
UMLS CUI [1]
C0005779
12. non-typical eating pattern
Description

Abnormal eating pattern

Type de données

boolean

Alias
UMLS CUI [1]
C0586278
13. is currently using diabetes-specific nutritional product(s)defined as more than one eating occasion per week.
Description

Nutritional products Diabetes Specific | Meal (occasion for eating) times/week

Type de données

boolean

Alias
UMLS CUI [1,1]
C4036031
UMLS CUI [1,2]
C0011847
UMLS CUI [1,3]
C0205369
UMLS CUI [2,1]
C1998602
UMLS CUI [2,2]
C0456698
14. engages in strenuous exercise five or more times per week.
Description

Strenuous Exercise times/week

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514989
UMLS CUI [1,2]
C0456698

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00753181

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
1. type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Glucohemoglobin measurement
Item
2. hba1c >6.5% and <11.0%
boolean
C0202054 (UMLS CUI [1])
Gender | Pregnancy Absent | Breast Feeding Absent | Postpartum
Item
3. male/non-pregnant, non-lactating female, at least 6 months postpartum
boolean
C0079399 (UMLS CUI [1])
C0032961 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0006147 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0086839 (UMLS CUI [4])
Childbearing Potential Contraceptive methods
Item
4. if female of childbearing potential, practicing method of birth control
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Body mass index
Item
5. body mass index > 18.5 kg/m2 and < 43.0 kg/m2.
boolean
C1305855 (UMLS CUI [1])
Stable body weight Duration
Item
6. weight stable for past two months
boolean
C0517386 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Antihypertensive Agents Dosage Stable | Hypoglycemic Agents Dosage Stable | Antithyroid Agents Dosage Stable | Hormone Therapy Dosage Stable
Item
7. if on anti-hypertensive, lipid-lowering, thyroid medication or hormone therapy, dosage constant for at least two months
boolean
C0003364 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0020616 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0040125 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C0279025 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0205360 (UMLS CUI [4,3])
Item Group
C0680251 (UMLS CUI)
Pharmaceutical Preparations Injection Blood Glucose Control | Insulin | exenatide
Item
1. uses injected medications (e.g., insulin, exenatide) for glucose control.
boolean
C0013227 (UMLS CUI [1,1])
C1828121 (UMLS CUI [1,2])
C0005802 (UMLS CUI [1,3])
C0243148 (UMLS CUI [1,4])
C0021641 (UMLS CUI [2])
C0167117 (UMLS CUI [3])
Diabetic Ketoacidosis
Item
2. history of diabetic ketoacidosis
boolean
C0011880 (UMLS CUI [1])
Communicable Disease | Inpatient Operative Surgical Procedures | Adrenal Cortex Hormones | Antibiotics
Item
3. current infection ; inpatient surgery, or corticosteroid treatment in the last 3 months or antibiotics in the last 3 weeks
boolean
C0009450 (UMLS CUI [1])
C0021562 (UMLS CUI [2,1])
C0543467 (UMLS CUI [2,2])
C0001617 (UMLS CUI [3])
C0003232 (UMLS CUI [4])
Malignant Neoplasms
Item
4. active malignancy
boolean
C0006826 (UMLS CUI [1])
Cardiovascular event | Congestive heart failure
Item
5. states he/she has had a significant cardiovascular event < 12 weeks prior to study entry or history of congestive heart failure in the last 12 months.
boolean
C1320716 (UMLS CUI [1])
C0018802 (UMLS CUI [2])
Organ failure End-stage
Item
6. end stage organ failure
boolean
C0349410 (UMLS CUI [1,1])
C0205088 (UMLS CUI [1,2])
Metabolic Disease Interferes with Nutrient absorption | Liver disease Interferes with Nutrient absorption | Gastrointestinal Disease Interferes with Nutrient absorption | Metabolic Disease Interferes with Nutrients Distribution | Liver disease Interferes with Nutrients Distribution | Gastrointestinal Disease Interferes with Nutrients Distribution | Metabolic Disease Interferes with Nutrients Metabolism | Liver disease Interferes with Nutrients Metabolism | Gastrointestinal Disease Interferes with Nutrients Metabolism | Metabolic Disease Interferes with Nutrients Excretion | Liver disease Interferes with Nutrients Excretion | Gastrointestinal Disease Interferes with Nutrients Excretion | Gastroparesis | Exception Diabetes
Item
7. active metabolic, hepatic, or gastrointestinal disease that may interfere with nutrient absorption, distribution, metabolism, or excretion (such as gastroparesis), excluding diabetes.
boolean
C0025517 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C1961155 (UMLS CUI [1,3])
C0023895 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C1961155 (UMLS CUI [2,3])
C0017178 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C1961155 (UMLS CUI [3,3])
C0025517 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0678695 (UMLS CUI [4,3])
C1378698 (UMLS CUI [4,4])
C0023895 (UMLS CUI [5,1])
C0521102 (UMLS CUI [5,2])
C0678695 (UMLS CUI [5,3])
C1378698 (UMLS CUI [5,4])
C0017178 (UMLS CUI [6,1])
C0521102 (UMLS CUI [6,2])
C0678695 (UMLS CUI [6,3])
C1378698 (UMLS CUI [6,4])
C0025517 (UMLS CUI [7,1])
C0521102 (UMLS CUI [7,2])
C0678695 (UMLS CUI [7,3])
C0025519 (UMLS CUI [7,4])
C0023895 (UMLS CUI [8,1])
C0521102 (UMLS CUI [8,2])
C0678695 (UMLS CUI [8,3])
C0025519 (UMLS CUI [8,4])
C0017178 (UMLS CUI [9,1])
C0521102 (UMLS CUI [9,2])
C0678695 (UMLS CUI [9,3])
C0025519 (UMLS CUI [9,4])
C0025517 (UMLS CUI [10,1])
C0521102 (UMLS CUI [10,2])
C0678695 (UMLS CUI [10,3])
C0221102 (UMLS CUI [10,4])
C0023895 (UMLS CUI [11,1])
C0521102 (UMLS CUI [11,2])
C0678695 (UMLS CUI [11,3])
C0221102 (UMLS CUI [11,4])
C0017178 (UMLS CUI [12,1])
C0521102 (UMLS CUI [12,2])
C0678695 (UMLS CUI [12,3])
C0221102 (UMLS CUI [12,4])
C0152020 (UMLS CUI [13])
C1705847 (UMLS CUI [14,1])
C0011847 (UMLS CUI [14,2])
Chronic disease | Communicable Disease | Tuberculosis | Hepatitis B | Hepatitis C | HIV Infection
Item
8. chronic, contagious, infectious disease, such as active tuberculosis, hepatitis b or c, or hiv.
boolean
C0008679 (UMLS CUI [1])
C0009450 (UMLS CUI [2])
C0041296 (UMLS CUI [3])
C0019163 (UMLS CUI [4])
C0019196 (UMLS CUI [5])
C0019693 (UMLS CUI [6])
Plant Preparations Affecting Blood Glucose | Dietary Supplements Affecting Blood Glucose | Pharmaceutical Preparations Illicit Affecting Blood Glucose
Item
9. use of herbals, dietary supplements, or medications, other than allowed medications, during past four weeks that could profoundly affect blood glucose.
boolean
C0949854 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0005802 (UMLS CUI [1,3])
C0242295 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0005802 (UMLS CUI [2,3])
C0013227 (UMLS CUI [3,1])
C0332266 (UMLS CUI [3,2])
C0392760 (UMLS CUI [3,3])
C0005802 (UMLS CUI [3,4])
Response Symptomatic Collection of blood specimen
Item
10. symptomatic in response to blood collection prior to enrollment into this study.
boolean
C0871261 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,3])
Blood Coagulation Disorders
Item
11. clotting or bleeding disorders.
boolean
C0005779 (UMLS CUI [1])
Abnormal eating pattern
Item
12. non-typical eating pattern
boolean
C0586278 (UMLS CUI [1])
Nutritional products Diabetes Specific | Meal (occasion for eating) times/week
Item
13. is currently using diabetes-specific nutritional product(s)defined as more than one eating occasion per week.
boolean
C4036031 (UMLS CUI [1,1])
C0011847 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,3])
C1998602 (UMLS CUI [2,1])
C0456698 (UMLS CUI [2,2])
Strenuous Exercise times/week
Item
14. engages in strenuous exercise five or more times per week.
boolean
C1514989 (UMLS CUI [1,1])
C0456698 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial